We revealed the inflammatory-immune pathways underlying CKD-related CAVD, and developed SLPI/MMP9-based CAVD diagnostic nomogram, which offered novel insights into future serum-based diagnosis and therapeutic intervention of CKD with CAVD. The gene discussed is MMP9; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.